(Q45392073)

14 December 2017

Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus (English)

1 reference

14 December 2017

1 reference

Katherine L O'Brien

2

0 references

Mathuram Santosham

7

object named as

Mathuram Santosham

1 reference

14 December 2017

8

Ruth A Karron

1 reference

14 December 2017

Joshua J Shinoff

1

1 reference

14 December 2017

Bhagvanji Thumar

3

1 reference

14 December 2017

Jana B Shaw

4

1 reference

14 December 2017

Raymond Reid

5

1 reference

14 December 2017

Wei Hua

6

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Journal of Infectious Diseases

14 December 2017

1 reference

14 December 2017

198

1 reference

14 December 2017

1007-1015

1 reference

14 December 2017

7

1 reference

Prospects for a respiratory syncytial virus vaccine

14 December 2017

1 reference

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

21 January 2018

1 reference

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

21 January 2018

1 reference

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

21 January 2018

1 reference

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

21 January 2018

1 reference

Respiratory syncytial virus infection in Navajo and White Mountain Apache children

21 January 2018

1 reference

Design of a group-randomized Streptococcus pneumoniae vaccine trial

21 January 2018

1 reference

Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection

21 January 2018

1 reference

Respiratory syncytial virus vaccine development

21 January 2018

1 reference

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

21 January 2018

1 reference

Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group

21 January 2018

1 reference

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

21 January 2018

1 reference

Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

21 January 2018

1 reference

Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response

21 January 2018

1 reference

Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus

21 January 2018

1 reference

The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo

21 January 2018

1 reference

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

21 January 2018

1 reference

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

21 January 2018

1 reference

Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus

21 January 2018

1 reference

The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes

21 January 2018

1 reference

Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis

21 January 2018

1 reference

Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

21 January 2018

1 reference

Influence of maternal antibodies on neonatal immunization against respiratory viruses.

21 January 2018

1 reference

Respiratory syncytial virus load predicts disease severity in previously healthy infants

21 January 2018

1 reference

Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/591460

1 reference

14 December 2017

1 reference